Barry Steele Buys 7,000 Shares of InfuSystem (NYSE:INFU) Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry Steele bought 7,000 shares of InfuSystem stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average cost of $8.71 per share, for a total transaction of $60,970.00. Following the purchase, the chief financial officer owned 96,590 shares of the company’s stock, valued at $841,298.90. The trade was a 7.81% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

InfuSystem Price Performance

INFU stock traded down $0.21 during mid-day trading on Tuesday, hitting $8.16. 244,052 shares of the stock were exchanged, compared to its average volume of 135,464. The business has a fifty day moving average price of $9.67 and a 200 day moving average price of $9.21. InfuSystem Holdings, Inc. has a 12 month low of $5.08 and a 12 month high of $11.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The stock has a market capitalization of $164.76 million, a price-to-earnings ratio of 134.86 and a beta of 1.49.

Analyst Upgrades and Downgrades

Separately, Roth Mkm reiterated a “buy” rating and set a $15.00 price target (up from $14.00) on shares of InfuSystem in a research report on Tuesday, February 24th. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, InfuSystem presently has an average rating of “Moderate Buy” and a consensus target price of $15.00.

Institutional Trading of InfuSystem

A number of institutional investors have recently made changes to their positions in the stock. Hillsdale Investment Management Inc. purchased a new position in shares of InfuSystem in the third quarter worth $4,665,000. Arrowstreet Capital Limited Partnership increased its position in shares of InfuSystem by 220.1% in the third quarter. Arrowstreet Capital Limited Partnership now owns 449,348 shares of the company’s stock valued at $4,655,000 after acquiring an additional 308,974 shares during the period. Ancora Advisors LLC bought a new position in shares of InfuSystem during the third quarter valued at about $2,096,000. Teton Advisors LLC purchased a new stake in shares of InfuSystem during the third quarter worth about $1,917,000. Finally, Jane Street Group LLC increased its holdings in InfuSystem by 943.1% during the 2nd quarter. Jane Street Group LLC now owns 186,159 shares of the company’s stock valued at $1,162,000 after purchasing an additional 168,312 shares during the period. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.